<DOC>
	<DOCNO>NCT01856959</DOCNO>
	<brief_summary>As non-selective bronchodilator , magnesium sulfate ( MgSO4 ) effective administer intravenously treatment patient acute severe asthma respond conventional therapy ( oxygen , nebulized salbutamol , corticosteroid ) , result earlier improvement clinical sign symptom asthma PEF . However , use intravenous MgSO4 administer common clinical practice , 's prone adverse effect side effect nausea , vomit , facial flushing , hypotension , decrease tendon reflexes treatment . The aerosolised route offer advantage low dosage , short time drug deliver airway smooth muscle low incidence side effect compare intravenous route . At present , study effect nebulized MgSO4 treatment acute asthma child , conclusion controversial .</brief_summary>
	<brief_title>Lung Function Changes Induced Asthma Children Treated With Inhaled MgSO4</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>know case control bronchial asthma ≧4 year age result positive acetylcholine provocation test followup visit receive corticosteroid ( inhaled systemic ) β2agonists theophyllines clinic day fever ( axillary temperature &gt; 38.5℃ ) history chronic disease like bronchopulmonary dysplasia cystic fibrosis history renal insufficiency know allergy acetylcholine , albuterol magnesium</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>magnesium sulfate</keyword>
	<keyword>nebulized</keyword>
	<keyword>lung function</keyword>
</DOC>